Phase 1 and pharmacokinetic study of weekly docosahexaenoic acid-paclitaxel, Taxoprexin®, in resistant solid tumor malignancies by Fracasso, Paula M, Picus, Joel, Wildi, Jonathan D, Goodner, Sherry A, Creekmore, Allison N, Gao, Feng, Govindan, Ramaswamy, Ellis, Matthew J, Tan, Benjamin R, Linette, Gerald P, Fu, ChauHwei J, Pentikis, Helen S, Zumbrun, Stephen C, Egorin, Merrill J, Bellet, Robert E

Get full text

A phase II study of UCN-01 in combination with irinotecan in patients with metastatic triple negative breast cancer by Ma, Cynthia X., Ellis, Matthew J. C., Petroni, Gina R., Guo, Zhanfang, Cai, Shi-rong, Ryan, Christine E., Craig Lockhart, A., Naughton, Michael J., Pluard, Timothy J., Brenin, Christiana M., Picus, Joel, Creekmore, Allison N., Mwandoro, Tibu, Yarde, Erin R., Reed, Jerry, Ebbert, Mark, Bernard, Philip S., Watson, Mark, Doyle, Laurence A., Dancey, Janet, Piwnica-Worms, Helen, Fracasso, Paula M.

Get full text

A Phase 1 study of UCN-01 in combination with irinotecan in patients with resistant solid tumor malignancies by Fracasso, Paula M., Williams, Kerry J., Chen, Ronald C., Picus, Joel, Ma, Cynthia X., Ellis, Matthew J., Tan, Benjamin R., Pluard, Timothy J., Adkins, Douglas R., Naughton, Michael J., Rader, Janet S., Arquette, Matthew A., Fleshman, James W., Creekmore, Allison N., Goodner, Sherry A., Wright, Lisa P., Guo, Zhanfang, Ryan, Christine E., Tao, Yu, Soares, Eliane M., Cai, Shi-rong, Lin, Li, Dancey, Janet, Rudek, Michelle A., McLeod, Howard L., Piwnica-Worms, Helen

Get full text

A phase I study of pegylated liposomal doxorubicin and temsirolimus in patients with refractory solid malignancies by Wang-Gillam, Andrea, Thakkar, Nilay, Lockhart, A. Craig, Williams, Kerry, Baggstrom, Maria, Naughton, Michael, Suresh, Rama, Ma, Cynthia, Tan, Benjamin, Lee, Wooin, Jiang, Xuntian, Mwandoro, Tibu, Trull, Lauren, Belanger, Stefanie, Creekmore, Allison N., Gao, Feng, Fracasso, Paula M., Picus, Joel

Get full text